McCann U D, Penetar D M, Shaham Y, Thorne D R, Sing H C, Thomas M L, Gillin J C, Belenky G
Department of Behavioral Biology, Walter Reed Army Institute of Research, Washington, DC.
Neuropsychopharmacology. 1993 Jun;8(4):345-56. doi: 10.1038/npp.1993.34.
Alpha-methyl-para-tyrosine (AMPT), a tyrosine hydroxylase inhibitor, was used to evaluate the physiologic role of central nervous system catecholamines in modulating alertness and mood. Forty healthy males were randomized to one of four conditions: AMPT in a rested condition; AMPT plus 40.5 hours of total sleep deprivation; placebo plus sleep deprivation; or placebo in a rested condition. Repeated measures of alertness and mood revealed that treatment with AMPT or sleep deprivation increased sleepiness, and combined treatment produced greater sleepiness than either treatment alone. In contrast, although combined treatment with AMPT and sleep deprivation led to large increases in negative mood, neither treatment alone produced consistent mood changes. These findings are consistent with the view that sleep deprivation is associated with decreased functional catecholamine neurotransmission. Furthermore, mood effects following sleep deprivation plus AMPT suggest that catecholamines may be involved in mood changes during sleep deprivation.
α-甲基-对酪氨酸(AMPT)是一种酪氨酸羟化酶抑制剂,被用于评估中枢神经系统儿茶酚胺在调节警觉性和情绪方面的生理作用。40名健康男性被随机分配到以下四种情况之一:休息状态下服用AMPT;AMPT加40.5小时的完全睡眠剥夺;安慰剂加睡眠剥夺;或休息状态下服用安慰剂。对警觉性和情绪的重复测量显示,服用AMPT或睡眠剥夺会增加嗜睡感,且联合治疗比单独任何一种治疗产生的嗜睡感更强。相比之下,虽然AMPT与睡眠剥夺联合治疗会导致负面情绪大幅增加,但单独任何一种治疗都不会产生一致的情绪变化。这些发现与以下观点一致,即睡眠剥夺与功能性儿茶酚胺神经传递减少有关。此外,睡眠剥夺加AMPT后的情绪效应表明,儿茶酚胺可能参与了睡眠剥夺期间的情绪变化。